Skip to main content

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.

Publication ,  Journal Article
Qiao, G; Wang, X; Zhou, L; Zhou, X; Song, Y; Wang, S; Zhao, L; Morse, MA; Hobeika, A; Song, J; Yi, X; Xia, X; Ren, J; Lyerly, HK
Published in: Clin Cancer Res
March 1, 2019

PURPOSE: We have assessed the combination of DC-CIK with S-1 plus cisplatin chemotherapy in advanced gastric cancer (AGC) and the role of mutational analysis of circulating tumor DNA (ctDNA) and T-cell receptor (TCR) repertoire in predicting clinical outcomes. PATIENTS AND METHODS: Consecutive patients (n = 63) with AGC were allocated to treatment with S-1 alone, S-1 plus cisplatin, DC-CIK combined with S-1 or DC-CIK combined with S-1 plus cisplatin. The primary endpoints were progression-free survival (PFS) and overall survival (OS) at 1 year; the secondary endpoints were disease control rate and analysis of ctDNA and TCR repertoire. RESULTS: The DC-CIK infusions were well tolerated with no serious adverse events. The disease control rates (CR+PR+SD) were 5.6%, 33.3%, 47.1%, and 76.9% in the S-1 alone, the S-1 plus cisplatin, DC-CIK combined with S-1 and DC-CIK combined with the S-1 plus cisplatin groups, respectively (P = 0.001). After adjusting for competing risk factors, treatment with DC-CIK combined with S-1 plus cisplatin was confirmed to be an independent predictor of PFS and OS (P = 0.001). A decrease in the frequency and number of mutations in ctDNA was observed in 19 patients (63.3%) following the DC-CIK infusions. Decreased ctDNA mutational frequency and restored TCR repertoire were associated with improved PFS and OS (P = 0.001). CONCLUSIONS: DC-CIK combined with S-1 plus cisplatin provided a favorable PFS and OS in patients with AGC and the combination therapy was safe with tolerable toxicities. Clinical efficacy correlated with decreases in ctDNA mutational profiles and restored TCR repertoire.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

March 1, 2019

Volume

25

Issue

5

Start / End Page

1494 / 1504

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tegafur
  • Stomach Neoplasms
  • Retreatment
  • Prospective Studies
  • Oxonic Acid
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qiao, G., Wang, X., Zhou, L., Zhou, X., Song, Y., Wang, S., … Lyerly, H. K. (2019). Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clin Cancer Res, 25(5), 1494–1504. https://doi.org/10.1158/1078-0432.CCR-18-2360
Qiao, Guoliang, Xiaoli Wang, Lei Zhou, Xinna Zhou, Yuguang Song, Shuo Wang, Lei Zhao, et al. “Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.Clin Cancer Res 25, no. 5 (March 1, 2019): 1494–1504. https://doi.org/10.1158/1078-0432.CCR-18-2360.
Qiao, Guoliang, et al. “Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.Clin Cancer Res, vol. 25, no. 5, Mar. 2019, pp. 1494–504. Pubmed, doi:10.1158/1078-0432.CCR-18-2360.
Qiao G, Wang X, Zhou L, Zhou X, Song Y, Wang S, Zhao L, Morse MA, Hobeika A, Song J, Yi X, Xia X, Ren J, Lyerly HK. Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clin Cancer Res. 2019 Mar 1;25(5):1494–1504.

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

March 1, 2019

Volume

25

Issue

5

Start / End Page

1494 / 1504

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tegafur
  • Stomach Neoplasms
  • Retreatment
  • Prospective Studies
  • Oxonic Acid
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Middle Aged